Home › Articles › Volume 8, Issue 3 › A Study on Intraocular Pressure Elevation after Intr...
Moradabad, India
Original Article
Ophthalmology

A Study on Intraocular Pressure Elevation after Intravitreal 4mg Triamcinolone Acetonide Injection in Treatment of Macular Edema among North India Population


Volume 8, Issue 3, Pages 5-8

Authors

Shipra Tripathi1, Amit Sood2
Affiliation:
1Assistant Professor, Department of Ophthalmology, Varun Arjun Medical College Banthara,
2Assistant Professor, Department of Ophthalmology, autonomous state Medical College, Shahjahnpur.

Corresponding Author

Amit Sood

Abstract

Background: Macular edema is one of the leading causes for impaired vision in some retinal vascular disorders. Recent clinical studies suggest that intravitreal injection of triamcinolone acetonide (IVTA) may be a therapeutic option for the treatment of macular edema. In 1995, Penfold et al reported a pilot study of intravitreal injection of 4mg of triamcinolone acetonide (IVTA) to treat exudative age-related macular degeneration with encouraging results. Subjects and Methods: A prospective, non-comparative study was performed with 100 patients (100 eyes) who received 4mg/0.1mL (40g/L) IVTA injection for macular edema and who were followed-up for a minimum of 3 months at the Department of Ophthalmology. Patients using steroid eye drops or systemic steroid, those previously treated with subconjunctival or subtenon steroid injection, and those with a history of glaucoma were excluded from the study. Results: Of the 100 eyes, 50 were from women and 50 were from men; the mean age was 56.3±11.4 years. Reason for the IVTA was progressive declining of visual acuity due to macular edema associated with retinal vein occlusion (60 eyes), or diabetic retinopathy (40 eyes). IOP increased significantly (p<0.001) from 14.95±2.83 mmHg preoperatively to a mean maximum of 19.01±5.92 mmHg postoperatively. Conclusion: According to our results, intravitreal injection of 4mg of triamcinolone acetonide can lead to significant IOP elevation in approximately one-third of patients, occurring at a mean of 4 weeks after injection. The findings of our study suggest that the IVTA in a dosage of 4 mg could lead to a secondary ocular hypertension.

Keywords

Intraocular Pressure, Intravitreal Injection, Macular Edema.

History

Received 01 September 2019

Accepted 01 September 2019

DOI

10.21276/ajmr.2019.8.3.OT2

Author Notes

Corresponding Author: Dr. Amit Sood, Assistant Professor, department of Ophthalmology, autonomous state Medical College, Shahjahnpur.

Open Access

It is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits authors to retain ownership of the copyright for their content, and allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited. https://creativecommons.org/licenses/by/4.0/

Copyright

Copyright: © the author(s), 2019.

Cite this Article

Formats

                                                
Actions
Download PDF
Metrics
10
Downloads
10
Views
Journal
Journal Asian Journal of Medical Research
Volume Volume 8
Issue Issue 3
Year 2019

Purchase access plans

Select the plan that best fits your need

Loading plans...

Statistics:

Views: 0
Downloads: 0

Asian Journal of Medical Research (AJMR) is an international, peer-reviewed, quarterly open-access journal publishing advanced research across medical specialties.

Quick Links

For Authors

© 2026 Asian Journal of Medical Research. All Rights Reserved.Designed and Developed By Kryoni